Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CORO1A antisense RNA 1 (CORO1A-AS1) is a long noncoding RNA (lncRNA) transcribed from the strand opposite the protein-coding CORO1A gene. As an antisense RNA, it may regulate the expression of CORO1A through mechanisms such as transcriptional interference or RNA-RNA interaction, though its specific functions, biological roles, and disease associations have not been distinctly established in the current literature. No drugs, biomarkers, or safety concerns are presently associated with CORO1A-AS1. Any therapeutic or disease relevance is hypothetical and would require further study[3].
Not applicable (no drugs known to target CORO1A-AS1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CORO1A antisense RNA 1 (CORO1A-AS1).